Prophylactic anticoagulation in Guillain-Barré syndrome: too much of a good thing?

Lilleker, J B; Lim, E A; Jones, M; Richardson, A M T

Lilleker, J B; Lim, E A; Jones, M; Richardson, A M T.

Afiliación

Lilleker JB; Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, UK.
Lim EA; Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, UK.
Jones M; Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, UK Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, UK.
Richardson AM; Greater Manchester Neurosciences Centre, Salford Royal NHS Foundation Trust, Salford, UK Institute of Brain, Behaviour and Mental Health, University of Manchester, Manchester, UK.

J Neurol Neurosurg Psychiatry ; 87(7): 795-7, 2016 07.

Article en En | MEDLINE | ID: mdl-26187723

Asunto(s)

Anticoagulantes; Síndrome de Guillain-Barré/complicaciones; Anticoagulantes/uso terapéutico; Heparina/uso terapéutico; Humanos; Persona de Mediana Edad; Estudios Retrospectivos; Traqueostomía/efectos adversos; Tromboembolia Venosa/prevención & control

Palabras clave

GUILLAIN-BARRE SYNDROME; INTENSIVE CARE; NEUROMUSCULAR

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Síndrome de Guillain-Barré / Anticoagulantes Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: J Neurol Neurosurg Psychiatry Año: 2016 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google